Nifty

:

23907.25

Sensex

:

79117.11

557.35 (2.39%)
1961.32 (2.54%)

Login

Nifty
Sensex

:
:

23907.25
79117.11

557.35 (2.39%)
1961.32 (2.54%)

Healthcare Global Enterprises Ltd.

Hospital & Healthcare Services

Rating :

N/A

BSE: 539787 | NSE: HCG

Watchlist

NSE BSE

378.35

05-Jul-2024

Open
High
Low
Previous Close

372.10
381.50
372.10
371.40

Volume
Traded Value (lacs)
52 Week High
52 Week Low

286045
1081.54
519.50
314.00

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

6,533.75
113.75
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

6,993.49
N/A
7.53

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

13.90
11.80
11.01

EBITDA CAGR (%)

10 Years
5 Years
3 Years

15.62
14.01
6.72

PAT CAGR (%)

10 Years
5 Years
3 Years

49.91
-
-3.59

P:E (Median)

8 Years
5 Years
3 Years

-
-
110.07

P:BV (Average)

8 Years
5 Years
3 Years

4.21
4.18
5.15

EV:EBITDA (Average)

8 Years
5 Years
3 Years

17.27
16.07
16.20

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var% Dec 23 Dec 22 Var%
Net Sales 306.67 282.75 8.46% 293.61 272.23 7.85% 280.38 258.67 8.39% 267.21 252.68 5.75%
Expenses 248.63 232.34 7.01% 243.72 224.69 8.47% 225.53 218.69 3.13% 220.48 203.06 8.58%
EBITDA 58.04 50.41 15.14% 49.89 47.54 4.94% 54.85 39.98 37.19% 46.73 49.62 -5.82%
EBIDTM 18.93% 17.83% 16.99% 17.46% 19.56% 15.46% 17.49% 19.64%
Other Income 10.24 2.13 380.75% 10.50 1.83 473.77% 4.12 3.56 15.73% 5.52 2.10 162.86%
Interest 20.16 10.98 83.61% 19.34 9.69 99.59% 14.09 9.57 47.23% 13.21 10.53 25.45%
Depreciation 27.13 23.28 16.54% 25.84 21.64 19.41% 25.19 23.06 9.24% 24.09 21.81 10.45%
PBT 20.99 18.28 14.82% 15.21 18.04 -15.69% 3.59 7.91 -54.61% 14.95 19.38 -22.86%
Tax 4.96 4.58 8.30% 3.49 4.35 -19.77% 5.35 3.73 43.43% 6.62 5.22 26.82%
PAT 16.03 13.70 17.01% 11.72 13.69 -14.39% -1.76 4.18 - 8.33 14.16 -41.17%
PATM 5.23% 4.85% 3.99% 5.03% -0.63% 1.62% 3.12% 5.60%
EPS 1.15 0.98 17.35% 0.84 0.98 -14.29% -0.13 0.30 - 0.60 1.02 -41.18%

Description Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var% Dec 23 Dec 22 Var%
Net Sales 553.54 486.94 13.68% 525.58 460.68 14.09% 494.63 441.71 11.98% 469.87 424.68 10.64%
Expenses 451.27 402.31 12.17% 434.67 386.37 12.50% 402.60 365.39 10.18% 391.25 349.17 12.05%
EBITDA 102.27 84.63 20.84% 90.91 74.31 22.34% 92.03 76.32 20.58% 78.62 75.51 4.12%
EBIDTM 18.48% 17.38% 17.30% 16.13% 18.61% 17.28% 16.73% 17.78%
Other Income 11.13 3.40 227.35% 8.81 2.42 264.05% 5.05 4.65 8.60% 6.07 3.65 66.30%
Interest 35.98 26.89 33.80% 33.71 25.55 31.94% 26.84 25.63 4.72% 29.46 27.08 8.79%
Depreciation 49.74 43.21 15.11% 47.01 41.01 14.63% 45.98 42.20 8.96% 44.16 40.77 8.31%
PBT 27.68 17.93 54.38% 19.00 10.17 86.82% 28.16 13.14 114.31% 11.07 11.31 -2.12%
Tax 6.97 7.14 -2.38% 5.36 6.87 -21.98% 4.76 7.48 -36.36% 7.63 7.10 7.46%
PAT 20.71 10.79 91.94% 13.64 3.30 313.33% 23.40 5.66 313.43% 3.44 4.21 -18.29%
PATM 3.74% 2.22% 2.60% 0.72% 4.73% 1.28% 0.73% 0.99%
EPS 1.29 0.97 32.99% 0.87 0.55 58.18% 1.53 0.60 155.00% 0.41 0.54 -24.07%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 1,147.87 1,099.29 1,005.57 849.83 608.86 688.33 640.50 586.27 545.03 471.13 420.15 Net Sales Growth 7.65% 9.32% 18.33% 39.58% -11.55% 7.47% 9.25% 7.57% 15.69% 12.13% Cost Of Goods Sold 255.29 245.71 236.28 210.32 138.46 146.57 153.31 155.15 149.39 133.56 131.38 Gross Profit 892.58 853.58 769.29 639.51 470.40 541.76 487.19 431.11 395.64 337.58 288.77 GP Margin 77.76% 77.65% 76.50% 75.25% 77.26% 78.71% 76.06% 73.53% 72.59% 71.65% 68.73% Total Expenditure 938.36 903.04 836.51 702.96 535.40 572.61 546.43 504.48 462.36 407.34 363.70 Power & Fuel Cost - 19.20 18.82 19.76 18.50 19.56 16.34 14.51 13.29 12.06 11.21 % Of Sales - 1.75% 1.87% 2.33% 3.04% 2.84% 2.55% 2.47% 2.44% 2.56% 2.67% Employee Cost - 197.15 175.03 156.63 136.72 142.69 130.32 115.58 98.06 84.69 68.95 % Of Sales - 17.93% 17.41% 18.43% 22.46% 20.73% 20.35% 19.71% 17.99% 17.98% 16.41% Manufacturing Exp. - 276.58 253.79 221.52 177.19 51.06 45.70 32.83 30.81 27.64 25.75 % Of Sales - 25.16% 25.24% 26.07% 29.10% 7.42% 7.14% 5.60% 5.65% 5.87% 6.13% General & Admin Exp. - 140.37 115.10 76.97 53.57 188.80 188.66 169.16 158.35 136.85 110.95 % Of Sales - 12.77% 11.45% 9.06% 8.80% 27.43% 29.46% 28.85% 29.05% 29.05% 26.41% Selling & Distn. Exp. - 0.00 0.00 0.00 0.00 9.25 3.05 3.11 6.82 6.78 11.86 % Of Sales - 0% 0% 0% 0% 1.34% 0.48% 0.53% 1.25% 1.44% 2.82% Miscellaneous Exp. - 24.04 37.48 17.75 10.95 14.68 9.05 14.14 5.63 5.75 11.86 % Of Sales - 2.19% 3.73% 2.09% 1.80% 2.13% 1.41% 2.41% 1.03% 1.22% 0.85% EBITDA 209.51 196.25 169.06 146.87 73.46 115.72 94.07 81.79 82.67 63.79 56.45 EBITDA Margin 18.25% 17.85% 16.81% 17.28% 12.07% 16.81% 14.69% 13.95% 15.17% 13.54% 13.44% Other Income 30.38 16.88 22.02 12.42 24.02 12.11 13.48 22.87 6.72 3.38 4.29 Interest 66.80 47.97 41.49 42.80 62.86 82.99 47.81 26.80 15.93 34.44 31.52 Depreciation 102.25 94.20 88.97 88.36 86.58 79.41 47.17 43.92 44.16 36.91 32.57 PBT 54.74 70.96 60.62 28.13 -51.96 -34.57 12.56 33.94 29.30 -4.17 -3.36 Tax 20.42 20.91 17.43 42.79 -13.51 -12.16 5.32 11.98 9.82 -3.91 -5.24 Tax Rate 37.30% 38.11% 30.25% 52.80% 6.59% 18.58% 42.36% 32.48% 33.52% 45.25% 68.86% PAT 34.32 33.96 40.19 38.25 -191.55 -53.30 7.25 24.89 19.48 -4.73 -2.37 PAT before Minority Interest 34.32 33.96 40.19 38.25 -191.55 -53.30 7.25 24.89 19.48 -4.73 -2.37 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 2.99% 3.09% 4.00% 4.50% -31.46% -7.74% 1.13% 4.25% 3.57% -1.00% -0.56% PAT Growth -24.95% -15.50% 5.07% - - - -70.87% 27.77% - - EPS 2.46 2.44 2.88 2.74 -13.74 -3.82 0.52 1.79 1.40 -0.34 -0.17

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 2,043.62 1,907.87 1,691.41 1,394.78 1,009.18 1,092.34 976.03 828.79 700.11 584.17 519.38 Net Sales Growth 12.66% 12.80% 21.27% 38.21% -7.61% 11.92% 17.77% 18.38% 19.85% 12.47% Cost Of Goods Sold 514.11 475.42 424.07 354.91 240.31 239.86 218.64 189.72 170.91 150.02 146.03 Gross Profit 1,529.51 1,432.45 1,267.35 1,039.88 768.87 852.48 757.39 639.07 529.20 434.15 373.34 GP Margin 74.84% 75.08% 74.93% 74.56% 76.19% 78.04% 77.60% 77.11% 75.59% 74.32% 71.88% Total Expenditure 1,679.79 1,582.53 1,411.17 1,159.81 886.86 923.46 853.48 716.44 595.12 499.41 443.14 Power & Fuel Cost - 39.35 36.89 34.54 31.75 33.26 28.82 22.89 16.42 14.35 13.29 % Of Sales - 2.06% 2.18% 2.48% 3.15% 3.04% 2.95% 2.76% 2.35% 2.46% 2.56% Employee Cost - 308.24 275.12 233.65 195.94 208.03 184.52 157.71 121.92 100.53 81.51 % Of Sales - 16.16% 16.27% 16.75% 19.42% 19.04% 18.91% 19.03% 17.41% 17.21% 15.69% Manufacturing Exp. - 520.39 456.89 391.27 316.75 73.40 62.84 41.50 36.63 31.47 30.26 % Of Sales - 27.28% 27.01% 28.05% 31.39% 6.72% 6.44% 5.01% 5.23% 5.39% 5.83% General & Admin Exp. - 204.67 176.67 118.64 85.52 333.09 333.69 277.59 230.94 186.02 152.59 % Of Sales - 10.73% 10.45% 8.51% 8.47% 30.49% 34.19% 33.49% 32.99% 31.84% 29.38% Selling & Distn. Exp. - 0.00 0.00 0.00 0.00 19.33 12.19 10.06 10.51 9.56 13.94 % Of Sales - 0% 0% 0% 0% 1.77% 1.25% 1.21% 1.50% 1.64% 2.68% Miscellaneous Exp. - 34.47 41.54 26.82 16.58 16.48 12.79 16.99 7.78 7.46 13.94 % Of Sales - 1.81% 2.46% 1.92% 1.64% 1.51% 1.31% 2.05% 1.11% 1.28% 1.06% EBITDA 363.83 325.34 280.24 234.97 122.32 168.88 122.55 112.35 104.99 84.76 76.24 EBITDA Margin 17.80% 17.05% 16.57% 16.85% 12.12% 15.46% 12.56% 13.56% 15.00% 14.51% 14.68% Other Income 31.06 21.19 31.63 15.67 21.20 10.27 10.06 19.28 9.67 3.99 4.81 Interest 125.99 108.74 103.50 97.77 119.17 137.65 69.91 42.35 23.00 38.33 34.23 Depreciation 186.89 174.36 163.47 158.28 159.22 148.44 85.08 71.46 56.83 44.08 39.25 PBT 85.91 63.44 44.90 -5.41 -134.85 -106.94 -22.39 17.81 34.84 6.34 7.58 Tax 24.72 26.39 27.25 48.85 -7.56 6.19 -2.50 10.24 11.80 -1.97 -1.68 Tax Rate 28.77% 39.19% 60.69% 54.76% 3.31% -5.79% 11.17% 35.83% 33.87% -729.63% -55.63% PAT 61.19 48.15 29.35 53.73 -193.46 -94.37 -13.81 21.93 22.17 -1.46 0.84 PAT before Minority Interest 57.02 41.33 17.63 38.92 -221.10 -113.13 -19.89 18.34 23.04 2.24 4.70 Minority Interest -4.17 6.82 11.72 14.81 27.64 18.76 6.08 3.59 -0.87 -3.70 -3.86 PAT Margin 2.99% 2.52% 1.74% 3.85% -19.17% -8.64% -1.41% 2.65% 3.17% -0.25% 0.16% PAT Growth 155.38% 64.05% -45.38% - - - - -1.08% - - EPS 4.39 3.45 2.11 3.85 -13.88 -6.77 -0.99 1.57 1.59 -0.10 0.06

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 1,188.59 1,145.12 1,097.69 923.78 614.51 644.72 638.44 545.19 524.30 271.66 Share Capital 139.29 139.12 139.01 125.36 88.69 87.92 86.90 85.71 85.08 69.98 Total Reserves 1,031.74 993.98 951.96 747.82 518.76 551.23 517.85 458.26 438.32 197.40 Non-Current Liabilities 625.87 363.79 330.77 373.47 662.47 389.06 199.50 116.66 138.37 250.17 Secured Loans 245.38 105.02 80.39 124.77 281.70 232.09 92.70 45.97 19.47 140.83 Unsecured Loans 15.15 7.70 1.64 22.36 33.25 114.06 80.04 77.61 118.84 106.58 Long Term Provisions 11.13 9.50 7.79 6.29 5.37 4.39 3.73 2.44 7.46 6.86 Current Liabilities 373.44 220.80 215.08 249.93 476.64 366.65 265.23 248.63 168.50 167.38 Trade Payables 132.37 109.00 96.33 81.29 99.14 106.34 114.42 105.37 97.29 74.72 Other Current Liabilities 122.68 95.56 104.00 92.97 265.97 204.27 99.36 97.46 67.20 60.28 Short Term Borrowings 101.42 0.00 0.63 67.02 103.99 49.99 46.24 41.27 0.47 29.27 Short Term Provisions 16.96 16.23 14.12 8.65 7.54 6.05 5.20 4.54 3.54 3.10 Total Liabilities 2,187.90 1,729.71 1,643.54 1,547.18 1,753.62 1,400.43 1,103.17 910.48 831.17 689.21 Net Block 938.08 787.63 773.84 745.17 914.33 546.79 492.00 442.12 444.37 404.78 Gross Block 1,510.41 1,274.55 1,176.63 1,058.23 1,140.86 692.70 590.81 510.82 639.42 566.34 Accumulated Depreciation 572.34 486.92 402.79 313.06 226.52 145.92 98.81 68.70 195.04 161.56 Non Current Assets 1,674.82 1,357.19 1,287.39 1,219.19 1,513.03 1,169.83 905.53 682.45 641.49 583.14 Capital Work in Progress 36.49 9.22 4.82 27.61 43.61 104.11 79.11 33.41 28.46 27.88 Non Current Investment 506.32 474.93 438.66 365.66 316.13 299.04 218.84 133.93 94.65 83.76 Long Term Loans & Adv. 129.21 77.77 62.33 73.03 147.07 122.73 91.83 53.18 68.48 57.65 Other Non Current Assets 64.72 7.64 7.75 7.74 91.88 97.16 23.74 19.80 5.52 9.07 Current Assets 513.07 372.52 356.16 327.99 240.58 230.61 197.64 228.03 189.67 106.08 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 7.49 60.00 0.00 Inventories 21.02 21.22 17.30 11.95 12.51 16.34 17.10 14.90 11.08 12.98 Sundry Debtors 204.17 212.37 160.25 147.48 152.32 145.60 126.21 100.60 78.56 64.38 Cash & Bank 237.33 80.36 119.96 14.46 15.14 8.54 15.31 74.58 17.57 12.77 Other Current Assets 50.55 14.43 29.03 21.60 60.61 60.13 39.01 30.46 22.46 15.95 Short Term Loans & Adv. 35.07 44.13 29.63 132.50 26.20 33.80 20.72 16.37 7.37 4.03 Net Current Assets 139.63 151.72 141.07 78.06 -236.06 -136.05 -67.59 -20.60 21.18 -61.30 Total Assets 2,187.89 1,729.71 1,643.55 1,547.18 1,753.61 1,400.44 1,103.17 910.48 831.16 689.22

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 825.78 860.52 870.29 697.18 381.25 476.65 515.10 432.66 425.82 279.49 Share Capital 139.29 139.12 139.01 125.36 88.69 87.92 86.90 85.71 85.08 69.98 Total Reserves 668.93 709.38 724.56 521.15 285.51 383.16 394.52 345.73 339.84 205.22 Non-Current Liabilities 1,091.62 871.01 860.11 822.06 1,231.51 557.18 394.05 354.08 305.83 278.51 Secured Loans 466.36 340.49 348.81 323.17 482.36 376.14 135.64 136.79 80.34 171.24 Unsecured Loans 18.95 21.25 14.07 23.00 47.25 140.77 148.05 146.59 165.49 109.00 Long Term Provisions 15.66 13.19 10.51 8.62 7.28 5.64 5.10 3.05 2.90 2.26 Current Liabilities 743.71 570.32 469.74 465.25 575.75 547.31 447.49 365.53 262.83 187.00 Trade Payables 281.06 248.45 193.94 145.52 153.57 152.75 142.47 127.36 108.42 83.27 Other Current Liabilities 335.56 298.85 253.17 241.94 317.31 337.27 204.97 190.21 113.41 70.99 Short Term Borrowings 106.59 3.44 4.82 67.02 93.66 49.99 90.47 41.63 37.18 29.27 Short Term Provisions 20.48 19.58 17.81 10.77 11.21 7.31 9.58 6.33 3.81 3.47 Total Liabilities 2,700.45 2,310.74 2,213.57 2,001.31 2,227.02 1,626.69 1,420.56 1,209.73 1,027.17 770.30 Net Block 1,758.16 1,553.00 1,547.14 1,382.38 1,646.08 970.21 827.72 684.70 582.96 528.50 Gross Block 2,780.75 2,419.31 2,254.74 1,933.10 2,024.62 1,197.40 970.11 773.36 620.21 719.54 Accumulated Depreciation 1,022.59 866.31 707.61 550.72 378.55 227.18 142.40 88.66 37.25 191.05 Non Current Assets 2,020.59 1,730.41 1,711.23 1,566.34 1,923.25 1,353.72 1,200.47 965.55 799.82 648.32 Capital Work in Progress 83.18 18.18 21.73 30.01 46.09 152.63 173.97 148.23 120.86 42.24 Non Current Investment 10.32 9.69 8.82 26.28 34.12 49.05 53.17 3.95 3.63 0.12 Long Term Loans & Adv. 149.70 116.31 98.52 98.34 161.10 128.08 95.50 82.10 66.62 67.56 Other Non Current Assets 19.21 33.22 35.04 29.33 35.86 53.75 50.11 46.58 25.75 9.90 Current Assets 679.85 580.34 502.34 434.96 303.79 272.96 220.09 244.18 227.35 121.97 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 7.49 60.02 0.00 Inventories 42.67 38.29 29.97 21.11 23.26 26.77 24.03 18.77 13.35 14.55 Sundry Debtors 294.03 302.51 217.44 186.60 185.66 156.89 128.44 103.22 69.54 63.81 Cash & Bank 303.07 196.64 197.51 40.85 32.02 20.87 28.80 85.22 57.61 26.95 Other Current Assets 40.08 12.34 12.55 14.63 62.85 68.44 38.83 29.47 26.82 16.66 Short Term Loans & Adv. 27.26 30.56 44.86 171.76 35.65 42.55 15.75 11.19 22.77 4.52 Net Current Assets -63.85 10.02 32.59 -30.29 -271.96 -274.35 -227.40 -121.35 -35.47 -65.02 Total Assets 2,700.44 2,310.75 2,213.57 2,001.30 2,227.04 1,626.68 1,420.56 1,209.73 1,027.17 770.29

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity 194.71 130.40 124.39 70.89 86.34 86.99 66.34 53.94 57.76 50.54 PBT 54.87 57.62 81.04 -205.06 -65.46 12.56 36.87 29.30 -8.64 -7.61 Adjustment 167.97 150.49 79.09 284.92 191.67 90.65 60.29 56.87 74.13 63.59 Changes in Working Capital 4.99 -60.47 -21.02 -49.41 -20.00 9.90 -32.30 -25.16 -0.21 -5.03 Cash after chg. in Working capital 227.83 147.64 139.12 30.45 106.21 113.11 64.86 61.01 65.28 50.95 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -33.12 -17.25 -14.72 40.43 -19.87 -26.12 1.49 -7.06 -7.52 -0.42 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -249.20 -137.70 48.65 -245.62 -116.00 -208.29 -184.58 -72.95 -85.54 -73.88 Net Fixed Assets -263.13 -102.32 -95.61 98.63 -387.66 -126.89 -125.69 123.65 -73.66 -91.33 Net Investments -31.39 -36.27 -73.00 -49.53 -17.09 -80.20 -77.42 13.23 -70.89 -3.75 Others 45.32 0.89 217.26 -294.72 288.75 -1.20 18.53 -209.83 59.01 21.20 Cash from Financing Activity 105.36 -41.71 -41.04 235.92 -2.76 66.28 91.03 -13.86 120.05 22.28 Net Cash Inflow / Outflow 50.87 -49.02 132.00 61.19 -32.41 -55.02 -27.21 -32.87 92.26 -1.06 Opening Cash & Equivalents 70.31 119.33 -12.68 -73.86 -41.45 13.58 40.81 73.67 -18.66 11.62 Closing Cash & Equivalent 121.18 70.31 119.33 -12.68 -73.86 -41.45 13.58 40.81 73.60 10.62

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity 284.58 251.59 220.12 120.52 130.14 98.50 97.81 91.28 73.20 59.65 PBT 67.73 44.88 87.77 -228.66 -119.26 -33.38 27.18 34.84 0.27 3.01 Adjustment 291.41 275.29 166.57 361.93 298.76 166.82 101.82 74.57 85.70 73.34 Changes in Working Capital -27.19 -45.87 -10.52 -50.71 -22.65 2.10 -26.98 -12.06 -1.91 -10.17 Cash after chg. in Working capital 331.95 274.31 243.83 82.55 156.85 135.55 102.02 97.35 84.07 66.18 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -47.37 -22.71 -23.70 37.97 -26.71 -37.05 -4.20 -6.07 -10.87 -6.53 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -225.73 -133.03 124.59 -171.10 -101.38 -238.20 -281.70 -209.80 -203.57 -79.71 Net Fixed Assets -263.13 -102.32 -95.61 98.63 -387.66 -126.89 -125.69 123.65 -73.66 -91.33 Net Investments -31.39 -36.27 -73.00 -49.53 -17.09 -80.20 -77.42 13.23 -70.89 -3.75 Others 68.79 5.56 293.20 -220.20 303.37 -31.11 -78.59 -346.68 -59.02 15.37 Cash from Financing Activity -64.02 -140.07 -154.88 112.24 -58.42 83.51 161.29 89.15 215.59 21.56 Net Cash Inflow / Outflow -5.16 -21.51 189.82 61.66 -29.67 -56.18 -22.60 -29.37 85.22 1.51 Opening Cash & Equivalents 171.18 192.69 2.87 -58.79 -29.12 27.06 51.08 80.45 -4.52 22.30 Closing Cash & Equivalent 166.02 171.18 192.69 2.87 -58.79 -29.12 27.06 51.08 80.45 24.75

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 84.07 81.45 78.48 69.65 68.49 72.70 69.59 63.46 61.01 38.21 ROA 1.73% 2.38% 2.40% -11.61% -3.38% 0.58% 2.47% 2.23% -0.62% -0.36% ROE 2.95% 3.61% 3.90% -25.87% -8.55% 1.16% 4.33% 3.67% -1.20% -0.90% ROCE 7.21% 8.02% 10.46% -12.55% 1.62% 6.13% 7.65% 6.12% 3.98% 4.42% Fixed Asset Turnover 0.79 0.82 0.76 0.55 0.75 1.00 1.06 1.11 0.91 0.79 Receivable days 69.15 67.63 66.08 89.86 78.99 77.45 70.61 56.84 51.73 50.17 Inventory Days 7.01 6.99 6.28 7.33 7.65 9.53 9.96 8.70 9.32 10.33 Payable days 179.28 158.60 154.13 237.82 255.84 101.72 108.65 106.61 104.34 87.25 Cash Conversion Cycle -103.12 -83.98 -81.76 -140.62 -169.20 -14.74 -28.08 -41.07 -43.29 -26.76 Total Debt/Equity 0.34 0.11 0.10 0.27 0.80 0.66 0.44 0.40 0.37 1.16 Interest Cover 2.14 2.39 2.89 -2.26 0.21 1.26 2.38 2.84 0.75 0.76

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 58.02 60.99 62.12 51.57 42.19 53.58 55.40 50.34 49.95 39.32 ROA 1.65% 0.78% 1.85% -10.46% -5.87% -1.31% 1.39% 2.06% 0.25% 0.64% ROE 4.99% 2.06% 5.16% -43.32% -26.77% -4.18% 4.02% 5.38% 0.64% 1.75% ROCE 12.79% 11.69% 15.17% -9.66% 2.75% 4.50% 7.75% 7.22% 5.60% 6.41% Fixed Asset Turnover 0.73 0.72 0.67 0.51 0.68 0.90 0.95 1.00 0.87 0.75 Receivable days 57.06 56.10 52.87 67.32 57.23 53.35 51.01 45.03 41.66 40.71 Inventory Days 7.74 7.36 6.68 8.02 8.36 9.50 9.42 8.37 8.72 9.32 Payable days 203.27 190.39 174.56 227.13 233.06 90.28 98.06 102.64 99.93 85.50 Cash Conversion Cycle -138.46 -126.92 -115.01 -151.79 -167.47 -27.43 -37.62 -49.23 -49.55 -35.46 Total Debt/Equity 0.83 0.47 0.47 0.73 1.91 1.40 0.96 0.97 0.76 1.27 Interest Cover 1.62 1.43 1.90 -0.92 0.22 0.68 1.67 2.52 1.01 1.09

Top Investors:

tata mutual fund - tata small cap fund

nippon life india trustee ltd-a/c nippon india els

international finance corporation

icici prudential pharma healthcare and diaganostic

clarus capital i

Annual Reports:

News Update:

Healthcare Global Enterprises to acquire oncology business of HCG NCHRI Oncology LLP
11th Nov 2024, 15:28 PM

The revenue of the Business Undertaking as per the unaudited financials for the half year ended September 30, 2024, was around Rs 43.50 crore
Read More
HealthcareGlobal - Quarterly Results
9th Nov 2024, 18:05 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback